Multidisciplinary: orally inhaled products

The European Medicines Agency's scientific guidelines on orally inhaled products help medicine developers prepare marketing authorisation applications for human medicines.

HumanAdvanced therapiesRegulatory and procedural guidanceInnovationResearch and developmentScientific guidelines

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

Guidelines

Requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)

Questions and answers

Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers

Topics

Advanced therapies
Regulatory and procedural guidance
Innovation
Research and development
Scientific guidelines

Multidisciplinary: orally inhaled products

Guidelines

Questions and answers

Related content

Topics

Share this page